Business Name: |
D. Scott Karempelis, M.D. |
Contact Person: |
Destiny Graber |
Address: |
5555 Peachtree Dunwoody Road NE Suite 190, Atlanta, Georgia 30342 |
Phone Number: |
(404) 256-4457 |
Website Address: |
dermatlanta.com |
Annual Revenue (USD): |
$500.000 to $999.999 |
Location Type: |
Single Location |
Employee Number: |
1 to 4 |
Business Type: |
B2C (Business to Consumer) |
Business Category: |
Doctors |
Share This Business: |
|
Related Businesses: |
Atlanta Oculoplastic Surgery P C - Atlanta, GA 30342 First Consultants Inc - Atlanta, GA 30342 Atlanta Ctr-Reconstructive - Atlanta, GA 30342 Dr Mervyn Forman Md - Atlanta, GA 30342 Atlanta Advanced Surgery Center - Atlanta, GA 30342 Fairbrother Genevieve L MD - Atlanta, GA 30342 Adventure MD - Atlanta, GA 30342 Berghoff Adar T MD - Atlanta, GA 30342 Eapen Betsy M DO - Atlanta, GA 30342 Clingan Josephine A MD - Atlanta, GA 30342 Gober Jr H F MD - Atlanta, GA 30342 Allen Jr Charles D MD - Atlanta, GA 30342 Chiu Wayne P MD - Atlanta, GA 30342 Creek Tracy L MD - Atlanta, GA 30342 Atlanta E N T Sinus & Allergy - Atlanta, GA 30342 Creed Karen C MD - Atlanta, GA 30342 Friedlander Adam D MD - Atlanta, GA 30342 Coles Robert A MD - Atlanta, GA 30342 Building Block Pediatrics - Atlanta, GA 30342 Alpert Hai MD - Atlanta, GA 30342 |
The company D. Scott Karempelis, M.D. provides B2C services in the form of Doctors from its single location in Georgia.
1 to 4 employees work for D. Scott Karempelis, M.D., and the business now earns $500.000 to $999.999 per annum.
D. Scott Karempelis, M.D. was launched in 0 and is classified under SIC code and category , and NAICS number and grouping .
To contact D. Scott Karempelis, M.D., please call Destiny Graber with the phone number (404) 256-4457 or visit its single location at 5555 Peachtree Dunwoody Road NE
Suite 190 in Atlanta, Georgia 30342.
The location of the single location can also be found using the coordinates 33.906040,-84.352860.
Read more details about this business on the webpage dermatlanta.com or follow the company’s social media accounts, on Twitter and on Facebook.